Trastuzumab (Herceptin)-associated lung injury

Respirology

Volumn 11, Issue 5, 2006, Pages 655-658

  Vahid, Bobbak ^a,b   Mehrotra, Anita ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Drug induced pneumonitis; Interstitial lung disease; Trastuzumab

Indexed keywords

METHYLPREDNISOLONE; TRASTUZUMAB;

AGED; ARTICLE; BREAST CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; FEMALE; HUMAN; LUNG LAVAGE; MEDICAL LITERATURE; METASTASIS; NEUTROPHILIA; PNEUMONIA; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LUNG; PNEUMONIA;

EID: 33746877839     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00907.x     Document Type: Article

References (7)

1. Tripathy D, Slamon DJ, Cobleigh M et al. Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J. Clin. Oncol. 2004; 22: 1063-70.
2. Anonymity. Herceptin (Trastuzumab). US Food and Drug Administration, 2005. [Cited 15 Nov 2005.]. Available from URL: http://www.fda.gov/medwatch/ safety/2005/Herceptin_Promo_PDF_Feb_2005.pdf
3. Clamon G, Herndon J, Kern J et al. Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of cancer and leukemia group B. Cancer 2005; 103: 1670-5.
4. Romond EH, Perez EA, Bryant J et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N. Engl. J. Med. 2005; 353: 1673-84.
5. Radzikowska E, Szczepulska E, Chabowski M, Bestry I. Organising pneumonia caused by transtuzumab (herceptin) therapy for breast cancer. Eur. Respir. J. 2003; 21: 552-5.
6. Atabai K, Ishigaki M, Geiser T, Ueki I, Matthay MA, Ware LB. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 283: 163-9.
7. Miettinen PJ, Warburton D, Bu D et al. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 1997; 186: 224-36.